Submitted by Anonymous (not verified) on 17 July 2025 - 12:54
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 10, Status: Authorised